ghk-cu subcutaneous injection sites recommendations Injectable GHK-Cu: Beginner's Guide to Copper Peptide GHK-Cu Dosage: Clinical Guidance for
Description
The cat is eating, active and has gained weight

Lu SC, Molecular Aspects of Medicine (2009) Examination of glutathione synthesis and regulatory control mechanisms

A large pulmonary embolism is serious, and can cause: heart problems lung and breathing problems cardiac arrest and sudden death Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare ongoing complication of pulmonary embolism

animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists